2 results
Approved WMOWill not start
To assess the safety of cisplatin doublets with hypofractionated radiotherapy (24 x2.75Gy).
Approved WMORecruiting
To compare the overall survival of patients with relapsed or refractory GCT treated with conventional-dose chemotherapy using the TIP regimen (CDCT) with patients treated with high-dose chemotherapy (HDCT) plus ASCT using the TI-CE regimen as…